|
Volumn 105, Issue 2, 2001, Pages 89-91
|
Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation
|
Author keywords
Bone marrow transplantation; CD94; Graft versus host disease; Graft versus leukemia; Killer cell inhibitory receptor
|
Indexed keywords
BUSULFAN;
CD3 ANTIGEN;
CD8 ANTIGEN;
CD94 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
ETOPOSIDE;
HLA ANTIGEN CLASS 1;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
TACROLIMUS;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ANTIGEN EXPRESSION;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL ARTICLE;
CONTROLLED STUDY;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNOSTIMULATION;
IMMUNOSUPPRESSIVE TREATMENT;
MONONUCLEAR CELL;
MYELODYSPLASTIC SYNDROME;
NATURAL KILLER CELL;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROPHYLAXIS;
ANTIGENS, CD;
ANTIGENS, CD3;
ANTIGENS, CD94;
BONE MARROW TRANSPLANTATION;
CASE-CONTROL STUDIES;
CD8-POSITIVE T-LYMPHOCYTES;
GRAFT VS HOST DISEASE;
HEMATOLOGIC NEOPLASMS;
HUMANS;
KILLER CELLS, NATURAL;
LECTINS, C-TYPE;
LEUKOCYTES, MONONUCLEAR;
MEMBRANE GLYCOPROTEINS;
RECEPTORS, IMMUNOLOGIC;
T-LYMPHOCYTES;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 17844366556
PISSN: 00015792
EISSN: None
Source Type: Journal
DOI: 10.1159/000046540 Document Type: Article |
Times cited : (12)
|
References (16)
|